France's Sanofi to acquire Synthorx in $2.5B deal

Note: This section contains information in English only.
Source: Dukascopy Bank SA
On Monday, France's Sanofi has agreed to acquire Synthorx in an all-cash deal worth about $2.5B, as the company seeks to boost its immuno-oncology pipeline.

Actual Topics